#zyn

#zyn

The Food and Drug Administration is holding a public meeting Thursday to consider whether Philip Morris International can advertise its pouches as a less-harmful alternative for adults who currently smoke cigarettes. Government documents posted before the meeting suggest FDA regulators are leaning toward approving the company's request. But the meeting will give an outside panel of health experts a chance to weigh in and ask questions of both the company and the agency.

Zyn's popularity has propelled parent company Philip Morris International's stock to all-time highs. PMI aims to raise awareness that Zyn is manufactured in the US.